Lung · Nov 4, 2026
Life-Course Exposure to PM2.5 Constituents and Major Respiratory Diseases: Constituent-Specific Associations and Candidate Immune-Metabolic Signatures in a Large Prospective Cohort
By Yang W, Zheng D, Zhuang Z et al.
Background Chronic obstructive pulmonary disease (COPD), asthma, lower respiratory tract infection (LRTI), and lung cancer have been identified as major respiratory diseases. Fine particulate matter (PM2.5) is an important respiratory risk factor, but evidence on life-course exposure to individual constituents and associated biological signatures remains limited. Methods Among 47,737 participants from UK Biobank, birth-to-baseline residential histories were linked to annual concentrations of PM2.5, sulfate (SO₄²⁻), nitrate (NO₃⁻), ammonium (NH₄⁺), organic carbon (OC), and elemental carbon (EC) estimated by the Community Multiscale Air Quality model during 1930–2010. Cox regression was used to estimate hazard ratios (HRs) per interquartile range (IQR) increase, and quantile g-computation to estimate mixture effects. Exposure- and disease-associated biomarkers were screened, followed by mediation analyses, protein functional enrichment, and metabolite categorization. Results During 13–14 years of follow-up, each IQR increase in PM2.5 was associated with higher risks of COPD (HR: 1.138, 95% CI 1.069–1.211), asthma (HR: 1.171, 95% CI 1.105–1.241), LRTI (HR: 1.046, 95% CI 1.002–1.091), and lung cancer (HR: 1.193, 95% CI 1.064–1.337). SO₄²⁻ and EC were positively associated with all four outcomes. Mixture analyses showed significant joint associations with COPD and asthma. Candidate proteins were enriched in immune-inflammatory, cell adhesion, PI3K-Akt, and cytokine/chemokine pathways, whereas candidate metabolites were predominantly lipoprotein-related. Conclusions Life-course exposures to PM2.5 and its constituents were associated with increased respiratory disease risks and candidate biological signatures. These findings highlight the relevance of PM2.5 chemical composition to major respiratory diseases and future mechanistic studies.
doi.org/10.1007/s00408-026-00948-1PubMed 42980807Populations